Susan Hasty, Publisher
Table of Contents . . . October 19th, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
HIV Gene Therapy - Antisense Enables Long-Term Survival of Transduced Immune Cells
Pancreatic Cancer - Sm-Like Oncogene is Novel Target for Gene Therapy
Animal Models - Immortomouse Hepatocytes Useful for Hepatic Gene Therapy Model
Bladder Cancer - p53 Gene Transfer Chemosensitizes Tumor in vivo
Cancer Gene Therapy - Scientists to Try Altering Gene Carrier to Improve its Ability to Bind to Cancer Cells
Lysosomal Storage Diseases - Intrahepatic Gene Therapy is Corrective in Murine Model
Prostate Cancer - p53 Adenovirus-Mediated Transfer Suppresses Primary Tumor Growth and Metastasis
Antisense Technology - Preclinical Study Data Reported for Oncogene Inhibitor
Melanoma - Phase I/II Clinical Trial Initiated for Gene Therapy Vaccine
Cancer Therapies - Expert Calls for New Thinking on Clinical Trials and Drug Spending
Colorectal Cancer - Mutations in Newly Discovered Gene Result in Defective Mismatch Repair
Functional Genomics - Agreement Focuses on High-Throughput Target Validation
Functional Genomics - Collaboration Will Study Therapeutic Drug Targets
Infectious Disease - Public Health Genetics Crucial to Treatment, Expert Says
Prostate Cancer - Leuvectin Phase II Trial Interim Data Presented
Prostate Cancer - Therapeutic Vaccine Selected for Human Testing
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.